Bayzed Health Group (HKG:2609) launched its initial public offering in Hong Kong that seeks to raise as much as HK$898.5 million, according to a Friday Hong Kong bourse filing.
The oncology-focused healthcare services provider is offering 133,105,800 shares at HK$4.22 to HK$6.75 apiece.
Bayzed secured Harvest International Premium Value (Secondary Market) Fund SPC, acting on behalf of Harvest Oriental SP, as a cornerstone investor, which committed to subscribe for up to $19 million worth of IPO shares.
The issuer expects to determine its offer price on June 19 and disclose the allocations on June 20. It will then start trading on the Hong Kong bourse on June 23, according to a stock exchange filing.
Proceeds from the deal will be used for expanding oncology services, acquiring hospitals, growing its hospital management business, upgrading IT systems, and general working capital.
CMB International Capital is the sole bookrunner of the IPO.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。